Deutsche Bank
OREX

Deutsche Bank’s Orexigen Therapeutics, Inc. OREX Stock Holding History

Deutsche Bank’s Portfolio OREX Stock Details OREX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-100
Closed – – 5366
2017
Q2 		$0 Sell
100
-100
-50% -$300 ﹤0.01% 5405
2017
Q1 		$0 Sell
200
-1,689
-89% -$6.67K ﹤0.01% 5371
2016
Q4 		$3K Sell
1,889
-60,985
-97% -$143K ﹤0.01% 4801
2016
Q3 		$208K Sell
62,874
-61,037
-49% -$231K ﹤0.01% 3633
2016
Q2 		$532K Sell
123,911
-61,932
-33% -$280K ﹤0.01% 3254
2016
Q1 		$1.04M Buy
185,843
+18,899
+11% +$245K ﹤0.01% 2779
2015
Q4 		$2.87M Sell
166,944
-121,338
-42% -$2.89M ﹤0.01% 2179
2015
Q3 		$6.08M Buy
288,282
+1,375
+0.5% +$47.1K ﹤0.01% 1659
2015
Q2 		$14.2M Buy
286,907
+24,441
+9% +$1.46M 0.01% 1128
2015
Q1 		$20.5M Buy
262,466
+7,592
+3% +$471K 0.01% 918
2014
Q4 		$15.4M Buy
254,874
+42,619
+20% +$2.14M 0.01% 1153
2014
Q3 		$9.04M Buy
212,255
+35,948
+20% +$1.93M 0.01% 1430
2014
Q2 		$10.9M Sell
176,307
-2,752
-2% -$160K 0.01% 1314
2014
Q1 		$11.6M Sell
179,059
-45,372
-20% -$3.07M 0.01% 1254
2013
Q4 		$12.6M Sell
224,431
-43,434
-16% -$2.44M 0.01% 1191
2013
Q3 		$16.4M Buy
267,865
+98,144
+58% +$6.65M 0.01% 997
2013
Q2 		$9.92M Buy
+169,721
New +$10.4M 0.01% 1250

Other funds holding OREX

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
OWIM
Old West Investment Management Los Angeles, California $923M AUM 112.31% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Deutsche Bank's OREX Position: Q3 2017 in Review

Deutsche Bank sold out of Orexigen Therapeutics, Inc. (OREX) in Q3 2017, closing a stake of 100 shares.

Deutsche Bank first reported a position in OREX in Q2 2013 and held it in 17 quarters. The position peaked at $20.5M in Q1 2015. 42 funds tracked by Wall St. Rank hold OREX as of Q3 2017.

  • Deutsche Bank reported no remaining Orexigen Therapeutics, Inc. position as of Q3 2017 after selling out during the quarter.
  • Deutsche Bank sold 100 Orexigen Therapeutics, Inc. shares in Q3 2017.
  • Deutsche Bank first reported a position in Orexigen Therapeutics, Inc. in Q2 2013 and held it in 17 quarters.
  • Deutsche Bank's Orexigen Therapeutics, Inc. position peaked at $20.5M in Q1 2015.
  • 42 funds tracked by Wall St. Rank held Orexigen Therapeutics, Inc. as of Q3 2017.

Based on Deutsche Bank's 13F filing for Q3 2017, filed 14 Nov 2017.